Krish S Krishnan sold $9.0M of KRYS
President and CEO at Krystal Biotech, Inc.. 25,000 shares at an average of $359.32, traded Sep 4, 2026, filed Sep 4, 2026.
Score components
- +25RoleCEO
- +25Trade size$9.0M at market
- 0Share of holdings soldSold 1.8% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001298709-26-000011, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | SOpen-market sale Common Stock10b5-1 | -520 | $354.54 | $184k | 1,372,023 | 38 d ago |
| Sep 4, 2026 | SOpen-market sale Common Stock10b5-1 | -2,029 | $355.57 | $721k | 1,369,994 | 38 d ago |
| Sep 4, 2026 | SOpen-market sale Common Stock10b5-1 | -3,297 | $356.37 | $1.2M | 1,366,697 | 38 d ago |
| Sep 4, 2026 | SOpen-market sale Common Stock10b5-1 | -3,981 | $357.57 | $1.4M | 1,362,716 | 38 d ago |
| Sep 4, 2026 | SOpen-market sale Common Stock10b5-1 | -3,143 | $358.42 | $1.1M | 1,359,573 | 38 d ago |
| Sep 4, 2026 | SOpen-market sale Common Stock10b5-1 | -3,357 | $359.39 | $1.2M | 1,356,216 | 38 d ago |
| Sep 4, 2026 | SOpen-market sale Common Stock10b5-1 | -2,266 | $360.46 | $817k | 1,353,950 | 38 d ago |
| Sep 4, 2026 | SOpen-market sale Common Stock10b5-1 | -1,214 | $361.61 | $439k | 1,352,736 | 38 d ago |
| Sep 4, 2026 | SOpen-market sale Common Stock10b5-1 | -2,010 | $362.65 | $729k | 1,350,726 | 38 d ago |
| Sep 4, 2026 | SOpen-market sale Common Stock10b5-1 | -573 | $363.34 | $208k | 1,350,153 | 38 d ago |
| Sep 4, 2026 | SOpen-market sale Common Stock10b5-1 | -1,358 | $364.48 | $495k | 1,348,795 | 38 d ago |
| Sep 4, 2026 | SOpen-market sale Common Stock10b5-1 | -847 | $365.42 | $310k | 1,347,948 | 38 d ago |
| Sep 4, 2026 | SOpen-market sale Common Stock10b5-1 | -405 | $366.56 | $148k | 1,347,543 | 38 d ago |
Related signals
Other insiders at Krystal Biotech, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | Krystal Biotech, Inc. | Suma Krishnan President, R&D | $9.0M 25,000 shares | -2% | |
| 45Moderate | Krystal Biotech, Inc. | Krish S Krishnan President and CEO | $8.9M 50,000 shares | -3% | |
| 40Moderate | Krystal Biotech, Inc. | Suma Krishnan President, R&D | $8.9M 50,000 shares | -3% | |
| 6Weak | Krystal Biotech, Inc. | Kathryn Romano Chief Accounting Officer | $131k 750 shares | -6% | |
| 38Weak | Krystal Biotech, Inc. | Krish S Krishnan President and CEO | $8.2M 50,000 shares | -3% | |
| 33Weak | Krystal Biotech, Inc. | Suma Krishnan President, R&D | $8.2M 50,000 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.